Literature DB >> 27852517

Regulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactions.

M S Golub1, C E Hogrefe2, A M Bulleri2.   

Abstract

Juvenile male rhesus macaques received therapeutic doses of fluoxetine daily from one to three years of age and were compared to vehicle-treated controls (N=16/group). Genotyping for monoamine oxidase A (MAOA) polymorphisms was used to form subgroups (N=8) with high and low expression of the gene. Behavioral responses were scored during 30-second exposures to pictures differing in affective content. As expected from its therapeutic effect, fluoxetine decreased the behavioral response to emotionally evocative pictures. A 44% reduction in number of expressive behaviors was seen, but only in subjects with low expression MAOA polymorphisms. In general, this effect occurred for pictures of varying affective content and was not due to altered occurrence of one specific behavior or type of behavior. The drug*genotype interaction was seen after one and two years of treatment and did not reverse one year after discontinuation of dosing. Two potential translational implications are suggested: (1) MAOA genetic polymorphisms may be the source of some of the variability in response to fluoxetine treatment in children; (2) extended fluoxetine treatment during juvenile brain development may result in persistent effects on emotional regulation. Copyright Â
© 2016 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Behavior; Children; Emotion; Fluoxetine; MAOA; Nonhuman primates

Mesh:

Substances:

Year:  2016        PMID: 27852517      PMCID: PMC5154301          DOI: 10.1016/j.euroneuro.2016.10.010

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  62 in total

1.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

2.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  MAOIs and depression treatment guidelines.

Authors:  Michael E Thase
Journal:  J Clin Psychiatry       Date:  2012-07       Impact factor: 4.384

4.  Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

Authors:  Jonathan R T Davidson; Edna B Foa; Jonathan D Huppert; Francis J Keefe; Martin E Franklin; Jill S Compton; Ning Zhao; Kathryn M Connor; Thomas R Lynch; Kishore M Gadde
Journal:  Arch Gen Psychiatry       Date:  2004-10

5.  What is an "adverse" environment? Interactions of rearing experiences and MAOA genotype in rhesus monkeys.

Authors:  Genesio M Karere; Erin L Kinnally; Jessica N Sanchez; Thomas R Famula; Leslie A Lyons; John P Capitanio
Journal:  Biol Psychiatry       Date:  2008-12-21       Impact factor: 13.382

6.  Nonhuman primate models to study anxiety, emotion regulation, and psychopathology.

Authors:  Ned H Kalin; Steven E Shelton
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

Review 7.  The National Institute of Mental Health Research Domain Criteria and Clinical Research in Child and Adolescent Psychiatry.

Authors:  Marjorie Garvey; Shelli Avenevoli; Kathleen Anderson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-11-22       Impact factor: 8.829

8.  MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction.

Authors:  Amy L Byrd; Stephen B Manuck
Journal:  Biol Psychiatry       Date:  2013-06-18       Impact factor: 13.382

9.  MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis.

Authors:  J Kim-Cohen; A Caspi; A Taylor; B Williams; R Newcombe; I W Craig; T E Moffitt
Journal:  Mol Psychiatry       Date:  2006-06-27       Impact factor: 15.992

Review 10.  The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment.

Authors:  Abbie Pringle; Catherine J Harmer
Journal:  Dialogues Clin Neurosci       Date:  2015-12       Impact factor: 5.986

View more
  4 in total

1.  Serotonin Transporter Binding Potentials in Brain of Juvenile Monkeys 1 Year After Discontinuation of a 2-Year Treatment With Fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe; Lillian J Campos; Andrew S Fox
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-07-06

2.  Cognitive performance of juvenile monkeys after chronic fluoxetine treatment.

Authors:  Mari S Golub; Edward P Hackett; Casey E Hogrefe; Csaba Leranth; John D Elsworth; Robert H Roth
Journal:  Dev Cogn Neurosci       Date:  2017-05-01       Impact factor: 6.464

Review 3.  Gene-environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions.

Authors:  Kent W Nilsson; Cecilia Åslund; Erika Comasco; Lars Oreland
Journal:  J Neural Transm (Vienna)       Date:  2018-06-07       Impact factor: 3.575

Review 4.  Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children.

Authors:  Mari S Golub; Casey E Hogrefe; Richard J Sherwood; Christoph W Turck
Journal:  Front Pediatr       Date:  2018-02-08       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.